“…21 The samples of infant-mother dyads were from a myriad of countries including Brazil, 40 Mexico, 16 Iran, 20 , 29 Saudi Arabia, 36 , 39 India, 21 , 30 Tanzania, 31 Poland, 17 Spain, 32 Kuwait, 33 Belgium, 34 China, 19 Argentina, 35 South Korea, 37 and South Eastern Nigeria. 38 Five of the studies 16,17,29,36,37 utilized longitudinal designs to evaluate infant anthropometric growth or developmental outcomes in relationship to maternal lead levels changes throughout pregnancy or to examine cognitive outcomes in infants exposure to Pb 2 + based on umbilical cord blood level samples. For context, when much of the data were collected, the Centers for Disease Control and Prevention (CDC) recommendation was Pb 2 + level 10 μ g/dL or less; however, a Pb 2 + level of 5 μ g/dL or more is considered a level 418 Allen of concern.…”